RT Journal Article
SR Electronic
T1 SARS-CoV-2 quarantine mandated by contact tracing: burden and infection rate among close contacts in Zurich, Switzerland, 2020-2021
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.09.03.23294798
DO 10.1101/2023.09.03.23294798
A1 Aschmann, Hélène E.
A1 Domenghino, Anja
A1 Jung, Ruedi
A1 Ballouz, Tala
A1 Menges, Dominik
A1 Fehr, Jan
A1 Puhan, Milo A.
YR 2023
UL http://medrxiv.org/content/early/2023/09/05/2023.09.03.23294798.abstract
AB Objectives Before vaccines and effective treatments were available, quarantine of close contacts was important to limit the spread of SARS-CoV-2. To evaluate potential benefits and harms of quarantine, we aimed to estimate infection rates and describe experiences and mental health among persons in mandated quarantine during the early SARS-CoV-2 pandemic.Methods We invited adults in mandated quarantine after an exposure to SARS-CoV-2 identified through contact tracing of the Canton of Zurich, Switzerland, between August 2020 and January 2021. Participants completed two questionnaires and received up to two SARS-CoV-2 polymerase chain reaction tests, during and at the end of quarantine.Results Among 395 participants, quarantine duration ranged from 2 to 20 days. By day 11 since the last contact, 11.1% [95% CI 8.4%–14.7%] were infected with SARS-CoV-2. The proportion of participants with symptoms of depression doubled from 9.3% before quarantine to 18.9% during quarantine, and 12.1% reported quarantine was very or extremely difficult.Conclusions Although quarantine was only moderately burdensome for most participants, some experienced significant difficulties and burden. Policymakers need to balance infection control with potential harms placed on individuals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe ZSAC study was funded through the Health Directorate of the Canton of Zurich and the Pandemic Fund of the University of Zurich. ZSAC was also part of the Corona Immunitas research program, coordinated by the Swiss School of Public Health (SSPH+) and funded through SSPH+ fundraising, including funding by the Swiss Federal Office of Public Health, the Cantons of Switzerland (Basel, Vaud, and Zurich), private funders (ethical guidelines for funding stated by SSPH+ were respected) and institutional funds of the participating universities. HEA was also supported by a Swiss National Science Foundation Early Postdoc.Mobility Fellowship [191414] and a Postdoc.Mobility Fellowship [214129]. TB received funding from the European Union's Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No 801076, through the SSPH+ Global PhD Fellowship Program in Public Health Sciences (GlobalP3HS) of the Swiss School of Public Health. Study funders had no role in the study design, data collection, analysis, interpretation, or writing of this report.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was prospectively registered (ISRCTN14990068) and approved by the ethics committee of the Canton of Zurich (BASEC 2020-01739).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesWe are open to sharing individual participant data that underlie the results reported in this article, after de-identification upon reasonable requests to the corresponding author. Data requestors will need to sign a data access agreement.